To determine the efficacy and safety of injection Labetalol Versus tablet Nifedipine in patients of severe pre-eclampsia

A Comparitive Study to Evaluate The Efficacy and Safety of Injection Labetalol Versus Tablet Nifedipine in patients of Severe pre-eclampsia in Tertiary care centre. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071651

Enrollment

Registered

2024-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O141- Severe pre-eclampsia

Interventions

Intervention1: Labetalol: 20 mg initially followed by 40 mg after 20 minutes then 80 mg every 20 minutes till the target blood pressure (150/100mmHg) is achieved. Control Intervention1: Nifedipine: 20

Eligibility

Inclusion criteria

Inclusion criteria: Women with Viable fetus at 20 weeks of gestation or more with severe pre-eclampsia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement in hypertensive condition of the patient with minimum dose required.Timepoint: Every 10 minutes till the target BP(150/110mmHg).	—

Secondary

Measure	Time frame
Adverse drug reaction of drugs.Timepoint: Every 10 minutes till the target BP(150/110mmHg).	—

Countries

India

Contacts

Public ContactDrRida Rizvi

Baba Raghav Das medical college,Gorakhpur

dranilk194@gmail.com8303060884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026